Implant Breast Reconstruction

2

Review clinical trials related to Implant Breast Reconstruction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based Reconstruction

This is a prospective, randomized controlled, non-inferiority clinical trial designed to compare the outcomes of hypofractionated radiotherapy versus conventionally fractionated radiotherapy following mastectomy and implant-based breast reconstruction. The primary objective is to evaluate whether hypofractionated radiotherapy is non-inferior to conventionally fractionated radiotherapy regarding the rate of unplanned reoperation.

Participants needed: 534
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Fudan UniversityUpdated: Sep 22, 2026Locations: 1
Eligibility criteria

Female patients aged ≥ 18 years. [+10]

Pregnant or lactating patients. [+6]

Status: Recruiting

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

Neoadjuvant radiotherapy(NART) followed by mastectomy and immediate DIEP flap reconstruction is feasible and technically safe. However, reports of NACT followed immediate implant-based breast reconstruction are rare. Some studies have shown that NART followed immediate implant-based breast reconstruction seems feasible and can be safely attempted. It's well known that radiotherapy after implant-based breast reconstruction have negative effects on implant and cosmetic results. So, investigators conducted a polit study to learn about acute post-surgical complications following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART.

Participants needed: 40
Trial details
Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Hubei Cancer HospitalUpdated: Mar 17, 2025Locations: 1
Eligibility criteria

require mastectomy for any reason [+2]

Inability to give informed consent [+4]